Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2006-06-30
2008-10-28
Guzo, David (Department: 1636)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C435S069100, C435S325000, C435S320100
Reexamination Certificate
active
07442551
ABSTRACT:
The present invention provides novel lentiviral packaging constructs that are useful for the establishment of stable packaging cell lines and producer cell lines. In particular, the present invention provides novel packaging cell lines that are capable of constitutively expressing high levels of lentiviral proteins.
REFERENCES:
patent: 5380830 (1995-01-01), Gonda
patent: 5994136 (1999-11-01), Naldini et al.
patent: 6207455 (2001-03-01), Chang
patent: 6277633 (2001-08-01), Olsen
patent: 6864085 (2005-03-01), Luo et al.
patent: 7070993 (2006-07-01), Kaleko et al.
patent: 2003/0104611 (2003-06-01), Johnston
patent: WO 96/19573 (1996-06-01), None
patent: WO 97/46687 (1997-12-01), None
patent: WO 98/39463 (1998-09-01), None
patent: WO 01/44458 (2001-06-01), None
patent: WO 01/68835 (2001-09-01), None
patent: WO 02/072851 (2002-09-01), None
PCT International Search Report for PCT/EP02/02807 dated Jun. 6, 2003.
Agarwal, et al., “Scaffold Attachment Region-Mediated Enhancement of Retroviral Vector Expression in Primary T Cells”,J. Virology, 72(5):3720-3728 (May 1998).
Auten, et al., “Effect of Scaffold Attachment Region on Transgene Expression in Retrovirus Vector-Transduced Primary T Cells and Macrophages”,Human Gene Therapy, 10:1389-1399 (May 20, 1999).
Berkowitz, et al., “Construction and Molecular Analysis of Gene Transfer Systems Derived from Bovine Immunodeficiency Virus”,Journal of Virology, 75(7):3371-3382 (Apr. 2001).
Beyer, et al., “Oncoretrovirus and Lentivirus Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus Glycoprotein: Generation, Concentration, and Broad Host Range”,J. Virology, 76(3):1488-1495 (Feb. 2002).
Carroll, et al., “A Human Immunodeficiency Virus Type 1 (HIV-1)-Based Retroviral Vector System Utilizing Stable HIV-1 Packaging Cell Lines”,J. Virology, 68(9):6047-6051 (Sep. 1994).
Dang, et al., “Human Beta Interferon Scaffold Attachment Region Inhibits De Novo Methylation and Confers Long-Term, Copy Number-Dependent Expression to a Retroviral Vector”,J. Virology, 74(6):2671-2678 (Mar. 2000).
Douglas, et al., “Efficient Human Immunodeficiency Virus-Based Vector Transduction of Unstimulated Human Mobilized Peripheral Blood CD34+ Cells in the SCID-hu Thy/Liv Model of Human T Cell Lymphopoieses”,Human Gene Therapy, 12:401-413 (Mar. 1, 2001).
Farson, et al., “Lentikat3™: Creation and Characterization of High Titer Third Generation Lentivirus Producer Clones in a VSV.G Packaging Cell Line”,Molecular Therapy, 5(5), No. 940 (May 2002).
Farson, et al., “A New-Generation Stable Inducible Packaging Cell Line for Lentiviral Vectors”,Human Gene Therapy, 12:981-997 (May 20, 2001).
Garvey, et al., “Nucleotide Sequence and Genome Organization of Biologically Active Proviruses of the Bovine Immunodeficiency-line Virus”,Virology, 175(2):391-409 (Apr. 1990).
Gossen, et al., “Tight Control of Gene Expression in Mammalian Cells by Tetracycline-Responsive Promoters”,Proc. Natl. Acad. Sci. USA, 89:5547-5551 (Jun. 1992).
Haselhorst, et al., “Development of Cell Lines Stably Expressing Human Immunodeficiency Virus Type 1 Proteins for Studies in Encapsidation and Gene Transfer”,Journal of General Virology, 79:231-237 (1998).
Junker, et al., “Intracellular Expression of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Variants Inhibits Replication of Wild-Type and Protease Inhibitor-Resistant HIV-1 Strains in Human T-Cell Lines”,J. Virology, 70(11):7765-7772 (Nov. 1996).
Kafri, et al., “A Packaging Cell Line for Lentivirus Vectors”,J. Virology, 73(1):576-584 (Jan. 1999).
Kaplan, et al., “Human Immunodeficiency Virus Type 1 Gag Proteins are Processed in Two Cellular Compartments”,Proc. Natl. Acad. Sci. USA, 88:4528-4532 (May 1991).
Kirillov, et al., “A Role for Nuclear NF-kappaB in B-Cell-Specific Demethylation of the Igkappa Locus”,Nature Genetics, 13(4):435-441 (1996).
Klehr, et al., “Scaffold-Attached Regions From the Human Interferon beta Domain Can Be Used to Enhance the Stable Expression of Genes Under the Control of Various Promoters”,Biochemistry, 30(5):1264-1270 (Feb. 5, 1991).
Konvalinka, et a., “An Active-Site Mutation in the Human Immunodeficiency Virus Type 1 Proteinase (PR) Causes Reduced PR Activity and Loss of PR-Mediated Cytotoxicity without Apparent Effect on Virus Maturation and Infectivity”,J. Virology, 69(11): 7180-7186 (Nov. 1995).
Korber, et al., “Limitations of a Molecular Clock Applied to Considerations of the Origin of HIV-1”,Science, 280:1868-1871 (Jun. 19, 1998).
Krausslich, et al., “Analysis of Protein Expression and Virus-Like Particle Formation in Mammalian Cell Lines Stably Expressing HIV-1 gag and env Gene Products With or Without Active HIV Proteinase”,Virology, 192(2):605-617 (Feb. 1993).
Mochizuki, et al., “High-Titer Human Immunodeficiency Virus Type 1-Based Vector Systems for Gene Delivery into Nondividing Cells”,Journal of Virology, 72(11):8873-8883 (Nov. 1998).
Naldini, et al., “In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector”,Science, 272:263-267 (1996).
Ory, et al., “A Stable Human-Derived Packaging Cell Line for Production of High Titer Retrovirus/Vesicular Stomatitis Virus G Pseudotypes”,Proc. Natl. Acad. Sci. USA, 93:11400-11406 (Oct. 1996).
Pacchia, et al., “An Inducible Packaging Cell System for Safe, Efficient Lentiviral Vector Production in the Absence of HIV-1 Accessory Proteins”,Virology, 282:77-86 (2001).
Rogel, et al., “The Human Immunodeficiency Virus Type 1 vpr Gene Prevents Cell Proliferation During Chronic Infection”,J. Virology, 69(2):882-888 (Feb. 1995).
Rosé, et al., “Defining the Level of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Activity Required for HIV-1 Particle Maturation and Infectivity”,Journal of Virology, 69(5):2751-2758 (May 1995).
Srinivasakumar, et al., “The Effect of Viral Regulatory Protein Expression on Gene Delivery by Human Immunodeficiency Virus Type 1 Vectors Produced in Stable Packaging Cell Lines”,J. Virology, 71(8):5841-5848 (Aug. 1997).
Sutton, et al., “Human Immunodeficiency Virus Type 1 Vectors Efficiently Transduce Human Hematopoietic Stem Cells”,J. Virology, 72(7):5781-5788 (Jul. 1998).
Zufferey, et al.,Nature Biotechnology, 15:871-875 (1997).
Kotsopoulou et al.,J. Virology, 74(10)4839-4852, 2000.
Haas et al.,Current Biology, 6(3)315-324, 1996.
Douglas Janet Lynn
Kaleko Michael
Luo Tianci
Plavec Ivan
Guzo David
MDIP LLC
Novartis AG
LandOfFree
Lentiviral packaging constructs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lentiviral packaging constructs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lentiviral packaging constructs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4007867